 |
Position
Associate Professor for Immunology
Cellular Immunology Lab
Comparative Genomics Centre
James Cook University
Molecular Sciences Bld. 21
Townsville, 4811, QLD, Australia
Tel: 61-7-4781 4563
Fax: 61-7-4781 6078
Email: heinrich.korner@jcu.edu.au
http://www.jcu.edu.au/school/pms/CGC/KornerHP.html
Research interests
Proinflammatory Cytokines in Leishmaniasis and Autoimmunity
Qualifications
Dipl Biol (Wuerzburg, Germany)
Dr. rer. Nat. (Wuerzburg, Germany)
10 Most Significant Publications
1) Körner H., Cook M., Riminton D. S., Lemckert F. A., Hoek R., Ledermann B., Köngten F., Fazekas de St. Groth B. and J. D. Sedgwick (1997) Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 27, 2600-2609.(IF 2007: 4.7; Cited: 167)
2) Körner H.*, Riminton D. S.*, Strickland D. H.*, Lemckert F. A., Pollard J. and J. D. Sedgwick (1997) Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med 186, 1585-1590.*These authors contributed equally to this study.(IF 2007: 15.6; Cited: 125)
3) Cook M.*, Körner H., Riminton D. S., Lemckert F. A., Hasbold J., Amesbury M., Hodgkin P. D., Cyster J. G., Sedgwick J. D. and A. Basten (1998) Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice J. Exp. Med. 188: 1503-1510. *Both authors contributed equally to this study. (IF 2007: 15.6; Cited: 33)
4) Ngo V. N., Körner H., Gunn M. D., Schmidt D. S., Riminton D. S., Cooper M. D., Browning J. L. Sedgwick J. D. and J. G. Cyster (1999) Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen . J. Exp. Med., 189: 403-412.(IF 2007: 15.6; Cited: 295)
5) Körner H., Cretney E., Wilhelm P., Kelly J. M., Röllinghoff M., Sedgwick J. D. and M. J. Smyth (2000) Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype. J. Exp. Med. 191: 89-96.(IF 2007: 15.6; Cited: 35)
6) Wilhelm P., Ritter U., Labbow S., Donhauser N., Röllinghoff M., Bogdan C, and H. Körner (2001) Rapidly Fatal Leishmaniasis in Resistant C57BL/6 Mice Lacking Tumor Necrosis Factor. J. Immunol. 166: 4012-4019.(IF 2007: 6.1; Cited: 62)
7) 7. Wilhelm P., Riminton D. S., Ritter U., Lemckert F. A., Scheidig C., Hoek R., Sedgwick J. D. and H. Körner (2002) Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs. Eur. J. Immunol. 32, 1993-2003. (IF 2007: 4.7; Cited: 22)
8) Wilhelm P., Wiede F., Meissner A., Donhauser N., Bogdan C. and H. Körner (2005) TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 mice. Microbes Infect. 7: 1461-1468. (IF 2007: 2.5; Cited: 1)
9) Wiede F., Vana K., Sedger L. M., Lechner A. and H. Korner (2007) TNF-dependent overexpression of CCL21 is an underlying cause of progressive lympho-accumulation in generalized lymphoproliferative disorder. Eur. J. Immunol., 37: 351-357.(IF 2007: 4.7; Cited: 0)
10) Lechner A., Ritter U., Varona R., Marquez G., Bogdan C. and H. Körner (2007) Protective Immunity and Delayed Type Hypersensitivity Reaction are Uncoupled in Experimental Leishmania major Infection of CCR6-negative Mice. Microbes Infect. 9: 291-299.(IF 2007: 2.5; Cited: 1)
Currently Held Grants
Jan. 2008
Grant from the Australian Multiple Sclerosis Society,
Title: Role of TNF and TLRs in EAE;
CI: Heinrich Koerner
|
